TAIANA, MICHELA MARIA
TAIANA, MICHELA MARIA
Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti
Side‐to‐side characterisation of cellular content, soluble factors and in vitro potential on chondrocytes for bone marrow aspirate concentrate and adipose‐derived stromal vascular fraction
2025 E. Ragni, M. Taiana, C. Visconte, E. Kon, S. Landoni, C. Colombo, L. Mangiavini, G. Peretti, L. De Girolamo
Targeting STMN2 for neuroprotection and neuromuscular recovery in Spinal Muscular Atrophy: evidence from in vitro and in vivo SMA models
2025 E. Pagliari, M. Taiana, P. Manzini, L. Sali, L. Quetti, L. Bertolasi, S. Oldoni, V. Melzi, G. Comi, S. Corti, M. Nizzardo, F. Rizzo
Dysfunction in IGF2R Pathway and Associated Perturbations in Autophagy and WNT Processes in Beckwith–Wiedemann Syndrome Cell Lines
2024 S. Pileggi, E.A. Colombo, S. Ancona, R. Quadri, C. Bernardelli, P. Colapietro, M. Taiana, L. Fontana, M. Miozzo, E. Lesma, S.M. Sirchia
Combined RNA interference and gene replacement therapy targeting MFN2 as proof of principle for the treatment of Charcot-Marie-Tooth type 2A
2023 F. Rizzo, S. Bono, M.D. Ruepp, S. Salani, L. Ottoboni, E. Abati, V. Melzi, C. Cordiglieri, S. Pagliarani, R. De Gioia, A. Anastasia, M. Taiana, M. Garbellini, S. Lodato, P. Kunderfranco, D. Cazzato, D. Cartelli, C. Lonati, N. Bresolin, G. Comi, M. Nizzardo, S. Corti
Molecular analysis of SMARD1 patient-derived cells demonstrates that nonsense-mediated mRNA decay is impaired
2022 M. Taiana, A. Govoni, S. Salani, N. Kleinschmidt, N. Galli, M. Saladini, S.B. Ghezzi, V. Melzi, M. Bersani, R. Del Bo, O. Muehlemann, E. Bertini, V. Sansone, E. Albamonte, S. Messina, F. Mari, E. Cesaroni, L. Porfiri, F.D. Tiziano, G.L. Vita, M. Sframeli, C. Bonanno, N. Bresolin, G. Comi, S. Corti, M. Nizzardo
Stathmins and Motor Neuron Diseases: Pathophysiology and Therapeutic Targets
2022 D. Gagliardi, E. Pagliari, M. Meneri, V. Melzi, F. Rizzo, G.P. Comi, S.P. Corti, M.M. Taiana, M. Nizzardo
Morpholino oligomers ameliorates pathological hallmarks in C9orf72 cellular lines and mice
2021 M. Bersani, D. Gagliardi, M. Taiana, F. Biella, M. Nizzardo, S. Corti
Human spinal cord-like organoids to model C9ORF72 ALS and test new therapies in vitro
2021 G. Costamagna, N. Galli, M. Rizzuti, B. Frizzi, F. Biella, M. Taiana, S. Ghezzi, I. Faravelli, G.P. Comi, M. Nizzardo, S. Corti
Dysregulation of Muscle-Specific MicroRNAs as Common Pathogenic Feature Associated with Muscle Atrophy in ALS, SMA and SBMA: Evidence from Animal Models and Human Patients
2021 C. Malacarne, M. Galbiati, E. Giagnorio, P. Cavalcante, F. Salerno, F. Andreetta, C. Cagnoli, M. Taiana, M. Nizzardo, S. Corti, V. Pensato, A. Venerando, C. Gellera, S. Fenu, D. Pareyson, R. Masson, L. Maggi, E. Dalla Bella, G. Lauria, R. Mantegazza, P. Bernasconi, A. Poletti, S. Bonanno, S. Marcuzzo
Impairment of the neurotrophic signaling hub B-Raf contributes to motoneuron degeneration in spinal muscular atrophy
2021 N. Hensel, F. Cieri, P. Santonicola, I. Tapken, T. Schüning, M. Taiana, E. Pagliari, A. Joseph, S. Fischer, N. Heidrich, H. Brinkmann, S. Kubinski, A.K. Bergmann, M.F. Richter, K. Jung, S. Corti, E. Di Schiavi, P. Claus
Optimization of AAV9 gene therapy for Spinal Muscular Atrophy with respiratory distress Type 1 using in vivo disease models
2020 E. Pagliari, P. Rinchetti, N. Galli, S. Ghezzi, M. Taiana, G. Comi, S. Corti, M. Nizzardo
Evaluation of Morpholino oligomers therapeutic efficacy in C9orf72 ALS iPSC-derived lines
2020 M. Bersani, M. Taiana, F. Biella, M. Nizzardo, S. Ghezzi, N. Bresolin, G.P. Comi, S. Corti
Changes in pathological phenotype of C9orf72 ALS iPSC-derived lines after treatment with Morpholino oligomers
2020 M. Bersani, M. Taiana, F. Biella, M. Nizzardo, S. Ghezzi, S. Corti
Insights into disease mechanisms and potential therapeutics for C9orf72-related amyotrophic lateral sclerosis/frontotemporal dementia
2020 D. Gagliardi, G. Costamagna, M. Taiana, L. Andreoli, F. Biella, M. Bersani, N. Bresolin, G.P. Comi, S. Corti
Synaptotagmin 13 is neuroprotective across motor neuron diseases
2020 M. Nizzardo, M. Taiana, F. Rizzo, J. Aguila Benitez, J. Nijssen, I. Allodi, V. Melzi, N. Bresolin, G.P. Comi, E. Hedlund, S. Corti
Current understanding of and emerging treatment options for spinal muscular atrophy with respiratory distress type 1 (SMARD1)
2020 M.G.L. Perego, N. Galli, M. Nizzardo, A. Govoni, M. Taiana, N. Bresolin, G.P. Comi, S. Corti
Spinal muscular atrophy with respiratory distress type 1: Clinical phenotypes, molecular pathogenesis and therapeutic insights
2020 M. Saladini, M. Nizzardo, A. Govoni, M. Taiana, N. Bresolin, G.P. Comi, S. Corti
IGHMBP2 related pathological pathways in Spinal Muscular Atrophy with Respiratory Distress type 1 (SMARD1) in vitro models
2019 N. Galli, M. Taiana, E. Pagliari, S. Ghezzi, G. Comi, S. Corti, M. Nizzardo
Key role of SMN/SYNCRIP and RNA-Motif 7 in spinal muscular atrophy: RNA-Seq and motif analysis of human motor neurons
2019 F. Rizzo, M. Nizzardo, S. Vashisht, E. Molteni, V. Melzi, M. Taiana, S. Salani, P. Santonicola, E. Di Schiavi, M. Bucchia, A. Bordoni, I. Faravelli, N. Bresolin, G.P. Comi, U. Pozzoli, S. Corti
R-Loops in Motor Neuron Diseases
2018 M.G.L. Perego, M. Taiana, N. Bresolin, G.P. Comi, S. Corti